What does Xenetic Biosciences, Inc. do?
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and…
What is Xenetic Biosciences, Inc.'s P/E and P/B ratio?
Xenetic Biosciences, Inc. has a P/E ratio of -1.7 and a P/B ratio of 0.74.
What is Xenetic Biosciences, Inc.'s debt-to-equity ratio?
Xenetic Biosciences, Inc. has a debt-to-equity ratio of 0.00.
How much does Xenetic Biosciences, Inc. owe compared with what it owns?
Xenetic Biosciences, Inc. owes $0.13 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Xenetic Biosciences, Inc.'s Positivity rank?
Xenetic Biosciences, Inc. is ranked #1,963 of 6,775 companies globally and #496 of 4,000 in United States on PositoAI, with a Positivity Score of 22,129.
Does Xenetic Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Xenetic Biosciences, Inc..
Where can I read the latest news about Xenetic Biosciences, Inc.?
Recent headlines about Xenetic Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Xenetic Biosciences, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Xenetic Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.